Author

C. B. Westphalen

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Sep 2026

Abstract IA012: A New Perspective: Clinical Trials in the Era of RAS Inhibitors

The demonstration of an overall survival benefit for RAS(ON) multi-selective inhibition in previously treated metastatic pancreatic ductal adenocarcinoma (RASolute 302) establishes the first randomised evidence for RAS-directed therapy in this disease. Previously, biomarker-directed treatment in PDAC reached a minori...

C. B. Westphalen · Cancer Research · 0 citations

Review Open access Sep 2026

Accelerating equitable cancer genomics and precision oncology in health care and research: a Lancet Oncology Commission.

The Commission developed a value-based resource-stratified implementation framework, a system-readiness assessment tool, a precision oncology workforce competency-based framework, a precision oncology monitoring and evaluation framework, and principles for responsible data sharing and health-system learning.

R. Casolino, J. Mateo, E. D. de Vries et al. · The Lancet Oncology · 11 citations